Antiplatelet monotherapy reduced bleeding, but dual therapy provided greater cardiovascular event protection in patients at high ischemic risk who had undergone stent implantation 12 months earlier. These results, from the A-CLOSE trial, were presented in a Hot Line session at ESC Congress 2026 and were published simultaneously in the New England Journal of Medicine.
The WHO-backed Africa Infodemic Response Alliance later linked at least 17 killings to the rumours, though some incidents could not be independently verified
Sector has avoided issue because of stigma fears, expert warns ahead of closure of Nottingham attacks inquiry Mental health organisations have “failed to acknowledge” the risk of violence from a…
